News

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...
Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. Here are some of the side ...
Some nutrition experts claim ‘Big Food’ is working overtime to push back against Ozempic as it threatens to eat into its ...
Actor Ethan Suplee wants people to understand what comes next after major weight loss: managing the excess skin.
In many ways, it’s the renaissance no one saw coming. After all, a decade ago, the British Association of Aesthetic Plastic ...
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.
Experts discuss how weight loss can trigger temporary hair loss, with hairstylists and an endocrinologist providing insights on managing symptoms and hair regrowth.
Rob Lowe opens up about staying fit at 61, what he thinks about Ozempic and his lifestyle with the Atkins diet.
GLP-1 drugs such as Wegovy, Ozempic and Mounjaro are transforming weight loss and reshaping the food industry - driving ...
Louisiana is facing a significant obesity challenge, ranking fourth in the nation for obesity rates. As a result, many residents are turning to weight loss drugs like ...